| Walmart Pharmcy 10-2341 | |
| 301 Falls Blvd, Quincy, Massachusetts 02169 | |
| (617) 745-4393 |
| Name | Walmart Pharmcy 10-2341 |
|---|---|
| Organization Name | Wal-mart Stores East Lp |
| Location | 301 Falls Blvd, Quincy, Massachusetts 02169 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (617) 745-4393 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Physicians from the USA and the Netherlands differ in their views on sedation at the end of life, with the Dutch justifying it by stating that it does not hasten death, and the Americans indicating that although it might hasten death, this is justifiable if it is not the primary intention, show study findings.
Few studies have examined the acute effects of alcohol on myocardial or heart function. While moderate-to-high blood concentrations of alcohol acutely impair conventional echocardiographic measures of left ventricular (LV) performance, the effects of low concentrations are unclear.
PDL BioPharma, Inc. announced today it has received a facsimile letter from Genentech asserting that Avastin, Herceptin, Lucentis and Xolair (the Genentech Products) do not infringe supplementary protection certificates granted by various countries in Europe to PDL and is seeking a response from PDL to these assertions.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced that the initial abstract for the investigator-sponsored clinical study of its RenalGuard System(TM) has been published, in advance of the annual meeting of the European Society of Cardiology, August 29 - September 2, 2009 in Barcelona, Spain, on the ESC website.
› Verified 7 days ago
| NPI Number | 1013934322 |
| Organization Name | WAL-MART STORES EAST LP |
| Doing Business As | WAL-MART PHARMACY 10-2341 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 301 Falls Blvd, Quincy, MA 02169 |
| Phone Number | 617-745-4393 |
News Archive
Physicians from the USA and the Netherlands differ in their views on sedation at the end of life, with the Dutch justifying it by stating that it does not hasten death, and the Americans indicating that although it might hasten death, this is justifiable if it is not the primary intention, show study findings.
Few studies have examined the acute effects of alcohol on myocardial or heart function. While moderate-to-high blood concentrations of alcohol acutely impair conventional echocardiographic measures of left ventricular (LV) performance, the effects of low concentrations are unclear.
PDL BioPharma, Inc. announced today it has received a facsimile letter from Genentech asserting that Avastin, Herceptin, Lucentis and Xolair (the Genentech Products) do not infringe supplementary protection certificates granted by various countries in Europe to PDL and is seeking a response from PDL to these assertions.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced that the initial abstract for the investigator-sponsored clinical study of its RenalGuard System(TM) has been published, in advance of the annual meeting of the European Society of Cardiology, August 29 - September 2, 2009 in Barcelona, Spain, on the ESC website.
› Verified 7 days ago
News Archive
Physicians from the USA and the Netherlands differ in their views on sedation at the end of life, with the Dutch justifying it by stating that it does not hasten death, and the Americans indicating that although it might hasten death, this is justifiable if it is not the primary intention, show study findings.
Few studies have examined the acute effects of alcohol on myocardial or heart function. While moderate-to-high blood concentrations of alcohol acutely impair conventional echocardiographic measures of left ventricular (LV) performance, the effects of low concentrations are unclear.
PDL BioPharma, Inc. announced today it has received a facsimile letter from Genentech asserting that Avastin, Herceptin, Lucentis and Xolair (the Genentech Products) do not infringe supplementary protection certificates granted by various countries in Europe to PDL and is seeking a response from PDL to these assertions.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced that the initial abstract for the investigator-sponsored clinical study of its RenalGuard System(TM) has been published, in advance of the annual meeting of the European Society of Cardiology, August 29 - September 2, 2009 in Barcelona, Spain, on the ESC website.
› Verified 7 days ago
Cvs Pharmacy #02454 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 321 Quincy Shore Dr, Quincy, Massachusetts 02171 Phone: (617) 471-0041 | |
Cvs Pharmacy #00137 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 626 S Artery, Quincy, Massachusetts 02169 Phone: (617) 472-7534 | |
Walgreens #18361 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 132 Granite St, Quincy, Massachusetts 02169 Phone: (617) 479-2330 | |
Stop & Shop Pharmacy # 20 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 65 Newport Ave, Quincy, Massachusetts 02171 Phone: (617) 328-6622 | |
Walgreens #04403 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 418 Quincy Ave, Quincy, Massachusetts 02169 Phone: (617) 472-4483 |